Towards Healthcare
Cell-Based Assays Market Size to Establish USD 39.92 Billion by 2034

Cell-Based Assays Market Outlook 2025 Dominance of HTS, Drug Discovery, and Immortalized Cell Lines

Market insights predict, the cell-based assays industry is expected to grow from USD 17.29 billion in 2024 to USD 39.92 billion by 2034, driven by a CAGR of 8.84%. The cell-based assays market is growing because it is mainly applied in drug discovery and development, basic research, clinical trials, biomarker monitoring, and immunogenicity assessment. North America is dominated due to significant research funding and a robust healthcare infrastructure.

Content

  • Insight Code: 5965
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

The cell-based assays market is projected to reach USD 39.92 billion by 2034, growing at a CAGR of 8.84% from 2024 to 2034.

North America is currently leading the cell-based assays market due to increasing advancements in cell-based therapy and rising government support for the biotech sector.

The cell-based assays market includes six segments such as by product & service, by application, by technology, by cell type, by end user, and by region.

Some key players include Thermo Fisher Scientific, Danaher Corporation, Becton, Dickinson and Company (BD), PerkinElmer, Merck KGaA, and Lonza Group.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions